Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
about
PET Imaging of the Human Nicotinic Cholinergic Pathway in AtherosclerosisSelected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh ReceptorsRadiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results.Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of σ₁ Receptors.LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors.Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
P2860
Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Internal dose assessment of (- ...... s with first-in-human results.
@en
Internal dose assessment of (- ...... s with first-in-human results.
@nl
type
label
Internal dose assessment of (- ...... s with first-in-human results.
@en
Internal dose assessment of (- ...... s with first-in-human results.
@nl
prefLabel
Internal dose assessment of (- ...... s with first-in-human results.
@en
Internal dose assessment of (- ...... s with first-in-human results.
@nl
P2093
P1476
Internal dose assessment of (- ...... s with first-in-human results.
@en
P2093
Alexander Hoepping
Alexander Starke
Andreas Schildan
Bernhard Sattler
Cornelius K Donat
Marianne Patt
Mathias Kranz
Osama Sabri
Peter Brust
P304
P356
10.2967/JNUMED.114.137059
P407
P577
2014-10-06T00:00:00Z